Robert W. Duggan - 25 Jul 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role: Director, 10%+ Owner
Signature: /s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol: PLSE
Transactions as of: 25 Jul 2023
Net transactions value: +$9,919
Form type: 4
Filing time: 27 Jul 2023, 09:09:51 UTC
Previous filing: 07 Jul 2023
Next filing: 28 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLSE	Common Stock	Options Exercise	$9,919	+1,667	+0%	$5.95	36,231,624	25 Jul 2023	Direct
holding	PLSE	Common Stock						492,069	25 Jul 2023	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLSE	Stock Option (right to buy)	Options Exercise	$0	-1,667	-9.1%	$0.000000	16,667	25 Jul 2023	Common Stock	1,667	$5.95	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.
F2	Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting.